Howard Hughes Holdings: Exec Buys Stock Amid Housing Boom by Mark Eisenberg 26.06.2024 "Howard Hughes Holdings Exec Elena Verbinskaya shows confidence in company by purchasing $22,390 in stock amid key developments and financial ...
Investment Firms Increase Stakes in Marvell Technology, Inc. by Lilu Anderson 23.06.2024 Wedmont Private Capital ups stake in Marvell Technology amid broader institutional interest; MRVL stock at $71.89, analysts set target at ...
Indie Semiconductor COO Sells $10K+ in Stock, Receives RSUs by Mark Eisenberg 22.06.2024 "Indie Semiconductor COO sells $10k+ in stock amid equity moves and company updates, spotlighting investor interest and market performance."
AbbVie Sets $1.55 Quarterly Dividend, Piper Sandler Ups Target by Mark Eisenberg 22.06.2024 AbbVie sets quarterly dividend at $1.55 per share, showcasing financial health and strategic growth. Recent acquisitions bolster positive outlook.
Converge Tech Solutions: Shareholders Approve Key Resolutions by Lilu Anderson 20.06.2024 "Converge Technology Solutions announces shareholder voting results from its June 19, 2024 AGM, including director elections and key resolutions."
Pakistan Regulator’s Edict Spurs $9bn Supply Chain Finance Market by Mark Eisenberg 19.06.2024 "Pakistan's regulator boosts the $9bn supply chain finance market with new initiatives, enhancing transparency and efficiency in trade."
Fisher Investments: $3B Strategic Partnership with Advent, ADIA by Mark Eisenberg 16.06.2024 Advent and ADIA invest $2.5-$3B, valuing Fisher Investments at $12.75B. Founder Ken Fisher sells holdings. New board member: Advent's Mussafer.
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive News by Terry Bingman 15.06.2024 Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.
Avidity Biosciences Director Sells $3.8M in Stock by Mark Eisenberg 15.06.2024 Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...
Nelson Peltz v. Disney: Proxy Battle Boosts Stock by Mark Eisenberg 05.04.2024 Nelson Peltz's Trian Group is pushing for two board seats at Disney, citing lack of engagement and accountability. Peltz has ...